KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Other Non-Current Liabilities (2016 - 2021)

Abbott Laboratories' Other Non-Current Liabilities history spans 13 years, with the latest figure at $3.7 billion for Q4 2021.

  • On a quarterly basis, Other Non-Current Liabilities changed 0.03% to $3.7 billion in Q4 2021 year-over-year; TTM through Dec 2021 was $3.7 billion, a 0.03% change, with the full-year FY2021 number at $3.7 billion, changed 0.03% from a year prior.
  • Other Non-Current Liabilities hit $3.7 billion in Q4 2021 for Abbott Laboratories, roughly flat from $3.7 billion in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for ABT hit a ceiling of $4.9 billion in Q4 2017 and a floor of $3.7 billion in Q4 2020.
  • Historically, Other Non-Current Liabilities has averaged $4.0 billion across 5 years, with a median of $3.9 billion in 2019.
  • Biggest five-year swings in Other Non-Current Liabilities: rose 6.73% in 2017 and later decreased 17.94% in 2018.
  • Tracing ABT's Other Non-Current Liabilities over 5 years: stood at $4.9 billion in 2017, then decreased by 17.94% to $4.0 billion in 2018, then decreased by 1.0% to $3.9 billion in 2019, then dropped by 6.59% to $3.7 billion in 2020, then increased by 0.03% to $3.7 billion in 2021.
  • Business Quant data shows Other Non-Current Liabilities for ABT at $3.7 billion in Q4 2021, $3.7 billion in Q4 2020, and $3.9 billion in Q4 2019.